Only 20% of drug wholesalers meet GMP

Source: on April 24, 2013, the 23rd Marketing Summit Forum of China Pharmaceutical Enterprise Management Association was held in Wuhan Liu Xiaoping, deputy director of Safety Supervision Department of State Food and drug administration, said in a speech that about 20% of drug wholesale enterprises and 15% of drug retail enterprises have basically met the basic standards of newly revised GMP Liu Xiaoping said that in the process of the new revision of the GMP, enterprises need to invest in the cost, and the situation is not the same everywhere According to the prediction, the total investment will not exceed 1% of the annual total commercial sales, and the reform fund of the whole industry will only need about 7 billion yuan From the current annual net profit level of 15.2 billion in drug circulation industry, the whole industry can bear the investment cost of 7 billion Liu Xiaoping, deputy director of the safety supervision department of the State Food and drug administration, believes that some small and poorly based small and medium-sized enterprises have some difficulties in facing the new version of GMP, but the situation is relatively better for large-scale enterprises with 20% of births If the newly revised GMP can be seriously implemented, the number of wholesale enterprises engaged in drug circulation services in China will be significantly reduced in the next few years, and a large number of enterprises will be eliminated In particular, some enterprises with poor ability, no resource advantage and low level, especially those in violation of laws and regulations, will surely be eliminated.